Evidence map›Paper›PMID 32815321›Full record

ArticleAdvanced biosystems2020

Plasmon-Enhanced Biosensing for Multiplexed Profiling of Extracellular Vesicles.

Jouha Min, Taehwang Son, Jae-Sang Hong, Pike See Cheah, Andreas Wegemann, Koushik Murlidharan, Ralph Weissleder, Hakho Lee, Hyungsoon Im

Abstract read
In one paragraph

Article in Advanced biosystems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Double Digital Assay for Single Extracellular Vesicle and Single Molecule Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  15. Article
  16. Article
  17. CRISPR/Cas13a-Based MicroRNA Detection in Tumor-Derived Extracellular Vesicles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  18. Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  19. Molecular Diagnosis and Cancer Prognosis-A Concise Review.Diagnostics (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jouha MinCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0002-6737-7254
Taehwang SonCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Jae-Sang HongCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Pike See CheahDepartment of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Andreas WegemannCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Koushik MurlidharanDepartment of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0003-0828-4143
Hakho LeeCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0002-0087-0909
Hyungsoon ImCenter for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0002-0626-1346

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHAREST, ALAIN · 1996 to 2021
$30.9M
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with NanoplasmonicsU01CA233360 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CASTRO, CESAR M, DINULESCU, DANIELA M · 2018 to 2022
$3.5M
Clinical platform for high-throughput analyses of extracellular vesiclesR01CA229777 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, HAKHO, SKOG, JOHAN · 2018 to 2022
$3.2M
Multiplexed analysis of exosomes in cancer nano therapyR01CA204019 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2016 to 2020
$1.9M
Novel Nano-Plasmonic Technology for Quantitative Analysis of Cancer ExosomesR00CA201248 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI IM, HYUNGSOON · 2017 to 2019
$968k
Nano-plasmonic technology for high-throughput single exosome analysesR21CA217662 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI IM, HYUNGSOON · 2019 to 2021
$585k
NCI NIH HHS P01 CA069246NCI NIH HHS R00 CA201248NCI NIH HHS R01 CA204019NCI NIH HHS R01 CA229777NCI NIH HHS R21 CA217662NCI NIH HHS U01 CA233360NIA NIH HHS P30 AG062421
6 · The paper itself

Abstract

Extracellular vesicles (EVs)-nanoscale phospholipid vesicles secreted by cells-present new opportunities for molecular diagnosis from non-invasive liquid biopsies. Single EV protein analysis can be extremely valuable in studying EVs as circulating cancer biomarkers, but it is technically challenging due to weak detection signals associated with limited amounts of epitopes and small surface areas for antibody labeling. Here, a new, simple method that enables multiplexed analyses of EV markers with improved sensitivities is reported. Specifically, plasmon-enhanced fluorescence detection is implemented that amplifies fluorescence signals using surface plasmon resonances excited by periodic gold nanohole structures. It is shown that fluorescence signals in multiple channels are amplified by one order of magnitude, and both transmembrane and intravesicular markers can be detected at the single EV level. This approach can offer additional insight into understanding subtypes, heterogeneity, and production dynamics of EVs during disease development and progression.

Indexed as

Biomarkers, TumorExtracellular VesiclesCell Line, TumorHumansMCF-7 CellsNeoplasmsSpectrometry, FluorescenceSurface Plasmon ResonanceBiomarkers, Tumorbiosensingcancerextracellular vesiclesnanoholesplasmon-enhanced fluorescence

Identifiers

PMID32815321
PMCPMC7718316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.